Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on TARGET HEALTHCARE REIT LTD. We currently have 3 research reports from 1 professional analysts.
|25Jan17 07:00||RNS||Corporate Update, Net Asset Value & Dividend|
|14Nov16 07:00||RNS||Acquisition of care home at Sutton-in-Ashfield|
|11Nov16 07:00||RNS||Result of AGM|
|11Nov16 07:00||RNS||Directorate Change|
|27Oct16 07:00||RNS||Corporate Update, Net Asset Value & Dividend|
|25Oct16 07:00||RNS||Acquisition of a Care Home in Tonbridge, Kent|
|18Oct16 17:05||RNS||Publication of Supplementary Prospectus|
Frequency of research reports
Research reports on
TARGET HEALTHCARE REIT LTD
TARGET HEALTHCARE REIT LTD
Pausing for breath
20 Oct 14
The media was rife with stories of IPO fatigue as the UK market went sideways for most of the third quarter. London listed investment companies managed to raise a total of c£1.2bn in Q3 2014, behind Q2’s £1.8bn. There were just two IPOs raising a total of £356m with a further £790m from secondaries. The sector is on target to hit total issuance of c£5bn for 2014, about two thirds of the £8.2bn raised in 2013. Pershing Square Holdings listed on the Amsterdam market just after the period end with $3bn of new money
Debt & renewables dominate
09 Jan 14
A total of £3.1bn was raised in the funds sector in the fourth quarter of 2013, exceeding total funds raised for the whole of 2012 (£2.7bn). The alternative asset and income theme continued to dominate, with most successful vehicles offering yields in excess of 5%.
Summary of fund raising in the sector
03 Oct 13
Three successful fund raises were announced this morning, two IPOs and one placing: - DP Aircraft I (Dr Peters) – IPO at £c70m with Canaccord (oversubscribed). - Chenavari Capital Solutions Fund (Asset Backed Securities) – IPO at c£130m with Dexion (50% of the target). - John Laing Infrastructure (JLIF) – £243m under a placing (the maximum) with JPM Cazenove. Next to announce are the two C-Shares from ABAA (Monday) and BRNA (Thursday). Updated Q4 fund raising table follows, almost at £3bn now at the top end of the targets.
21 Feb 17
Lighthouse Group* (LGT): Middle Britain growth (CORP) | Utilitywise* (UTW): Double-digit sales growth (CORP) | Trakm8* (TRAK): Earnings expectations cut again (CORP) | dotDigital* (DOTC): Myriad growth opportunities (CORP) | Artilium* (ARTA): Five-year Telenet deal secured and prepaid (CORP) | Netcall* (NET): Cloud investment pays off (CORP)
Small Cap Breakfast
16 Feb 17
Saffron Energy—Schedule One update. Raising £2.5m, expected Mkt Cap £7.7m. Admission due 24 Feb. Italian Oil & Gas Play Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime. Issue closing 23 Feb. Arix Bioscience — Intention to float on the main market from the global healthcare and life science Company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management
Industry fundamentals remain positive
21 Feb 17
The Biotech Growth Trust (BIOG) is a specialist vehicle, aiming to generate long-term capital growth via investment in global biotech stocks. Following a particularly volatile period for the biotech industry, where concerns about drug pricing and investor risk aversion have weighed heavily on stock prices, the managers are hopeful that greater clarity regarding US healthcare policy will lead to continued improved performance of biotech stocks. Industry fundamentals remain attractive, including continued innovation and valuations are very supportive, which offers the potential for higher industry merger and acquisition activity.
13 Feb 17
Surface Transforms* (SCE): H1 results confirm operational progress (CORP) | Premaitha Health* (NIPT): European diagnostics partnership (CORP) | Lok'nStore* (LOK): Filling existing stores, developing new ones (CORP) | Victoria* (VCP): Entry into the European flooring market (CORP) | eg solutions* (EGS): Exceptional H2 performance (CORP)
Share & share alike
14 Feb 17
The rally in the last fortnight, highlighted in the table, reflects a continued flow of positive updates and economic news. The FTSE 250, Small cap and Fledgling indices have reached record highs. We are in the lull ahead of results for those companies with a December year end, a welter of economic data regarding the UK economy, the State of the Union address in the US on 28 February and the UK Budget on Wednesday 8 March. We will learn at that stage the latest forecasts from the Office of Budget Responsibility. As highlighted previously, the reaction to corporate updates will continue to set the tone.
Middle Britain growth
21 Feb 17
The Company has achieved our 2017 estimate in 2016 with EBITDA of £2.2m, up 37% on 2015. We upgrade our estimates by 10% at the EBITDA level in 2017. If the shares traded even at the lower end of comparators, they would trade at 17p. We expect the share price to reach our upgraded 17p price target in the short term. Few companies enjoy the unique positioning which Lighthouse has to benefit from the assets of Middle Britain.